Business
Result of WRAP Retail Offer and TVR
ImmuPharma PLC has announced the results of its WRAP Retail Offer, raising gross proceeds of £468,746.82 from the issuance of 7,812,447 WRAP Retail Offer Shares. Combined with the Subscription, the total gross proceeds raised are approximately £6.468 million through the issuance of 107,812,447 shares. Additionally, 12,000,000 Value Payment Shares and 1,375,000 Fee Shares are being issued. Shareholder approval is required at a General Meeting on April 7, 2026, with admission of all new ordinary shares, totaling 121,187,447, expected on April 8, 2026, bringing the total issued ordinary share capital to 623,911,379. Disclaimer*
About this update from Immupharma Plc
[{"type":"text","content":"\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.\n \nTHIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (\"FSMA\") AND HAS BEEN APPROVED BY WINTERFLOOD SECURITIES LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 141455).\n \n \n23 March 2026\n \nImmuPharma PLC\n(\"ImmuPharma\" or the \"Company\")\n \nResult of WRAP Retail Offer and TVR\n \nImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, further to its Fundraising announcement published on 17 March 2026 at 7:00 a.m. (the \"Fundraising RNS\") and the WRAP Retail Offer announcement published on 17 March 2026 at 7:01 a.m. (the \"WRAP RNS\"), announces the result of the WRAP Retail Offer and provide an update on the Fundraising.\n \nThe Company has raised gross proceeds of £468,746.82 from the WRAP Retail Offer at the Issue Price and will, accordingly, issue 7,812,447 WRAP Retail Offer Shares pursuant to the WRAP Retail Offer.\n \nAccordingly, in total, the Subscription and the WRAP Retail Offer have raised gross proceeds of approximately £6.468m for the Company, via the issue of the 100,000,000 Subscription Shares and the 7,812,447 WRAP Retail Offer Shares all at the Issue Price.\n \nAdditionally, as detailed in the Fundraising RNS, the Company is also issuing 12,000,000 Value Payment Shares and 1,375,000 Fee Shares at the Issue Price.\n \nThe allotment of the Subscription Shares, WRAP Retail Offer Shares, Value Payment Shares and Fee Shares requires prior approval by the Company's Shareholders at the General Meeting which is scheduled for 11.00 a.m. on 7 April 2026. Contingent on approval of the Resolutions at the General Meeting Admission is expected to take place at 8.00 a.m. on 8 April 2026.\n \nAdmission and Total Voting Rights\n \nApplication will be made for a total of 121,187,447 new Ordinary...